These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19266254)

  • 1. A case of lung tuberculosis in a patient with rheumatoid arthritis treated with infliximab after antituberculosis chemoprophylaxis with isoniazid.
    Hirano Y; Kojima T; Kanayama Y; Ishikawa H; Ishiguro N
    Mod Rheumatol; 2009; 19(3):323-8. PubMed ID: 19266254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.
    Sichletidis L; Settas L; Spyratos D; Chloros D; Patakas D
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1127-32. PubMed ID: 17044206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measures for tuberculosis in compromised hosts--mainly on chemoprophylaxis].
    Yamagishi F
    Kekkaku; 2003 Oct; 78(10):661-7. PubMed ID: 14621575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of tuberculosis in a patient treated with infliximab who had received prophylactic therapy with isoniazid.
    Parra Ruiz J; Ortego Centeno N; Raya Alvarez E
    J Rheumatol; 2003 Jul; 30(7):1657-8. PubMed ID: 12858475
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development of cervical tuberculous lymphadenitis in a patient with Crohn's disease receiving infliximab despite of chemoprophylaxis with isoniazid].
    Ikeue T; Nakagawa A; Furuta K; Morita K; Sugita T; Nishiyama H
    Kekkaku; 2011 Nov; 86(11):879-82. PubMed ID: 22250467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case of rheumatoid arthritis presenting with pulmonary tuberculosis].
    Katoh K; Taniguchi H; Okouchi A; Kudo M; Kawai T
    Nihon Kokyuki Gakkai Zasshi; 2004 Aug; 42(8):782-6. PubMed ID: 15455955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
    Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD;
    Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary tuberculosis associated to adalimumab: a study of 3 cases].
    Blanco Pérez JJ; Aranda Torres A; Pego Reigosa JM; Núñez Delgado M; Temes Montes E; Guerra Vales JL
    Arch Bronconeumol; 2010 Apr; 46(4):203-5. PubMed ID: 19896259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemoprophylaxis for tuberculosis].
    Yamagishi F
    Kekkaku; 2005 Oct; 80(10):647-53. PubMed ID: 16296393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal-change nephrotic syndrome associated with isoniazid in anti-tuberculosis chemoprophylaxis for a patient with rheumatoid arthritis.
    Mori S; Matsushita Y; Arizono K
    Intern Med; 2011; 50(3):253-7. PubMed ID: 21297330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of interstitial pneumonia in a patient with rheumatoid arthritis induced by isoniazid for tuberculosis chemoprophylaxis.
    Migita K; Umeno T; Miyagawa K; Izumi Y; Sasaki E; Kakugawa T; Ito M; Kinoshita A; Miyashita T
    Rheumatol Int; 2012 May; 32(5):1375-7. PubMed ID: 20349068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case of miliary tuberculosis during treatment with infliximab for rheumatoid arthritis].
    Taniguchi H; Izumi S
    Kekkaku; 2008 May; 83(5):431-4. PubMed ID: 18536334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed response to anti-tuberculosis treatment in a patient on infliximab.
    Vlachaki E; Psathakis K; Tsintiris K; Iliopoulos A
    Respir Med; 2005 May; 99(5):648-52. PubMed ID: 15823465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis for latent tuberculosis infection prior to anti–tumor necrosis factor therapy in low-risk elderly patients with rheumatoid arthritis: a decision analysis.
    Hazlewood GS; Naimark D; Gardam M; Bykerk V; Bombardier C
    Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1722-31. PubMed ID: 23836530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-activation of bovine tuberculosis in a patient treated with infliximab.
    Larsen MV; Sørensen IJ; Thomsen VØ; Ravn P
    Eur Respir J; 2008 Jul; 32(1):229-31. PubMed ID: 18591340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive therapy and tuberculosis].
    Yoshikawa K; Yano S
    Kekkaku; 2010 Jan; 85(1):33-45. PubMed ID: 20232543
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.
    Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Romanus V; Klareskog L; Feltelius N
    Arthritis Rheum; 2005 Jul; 52(7):1986-92. PubMed ID: 15986370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNFalpha (adalimumab) treatment.
    Efde MN; Houtman PM; Spoorenberg JP; Jansen TL
    Neth J Med; 2005 Mar; 63(3):112-4. PubMed ID: 15813424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution to Mycobacterium tuberculosis after discontinuing infliximab.
    Belknap R; Reves R; Burman W
    Int J Tuberc Lung Dis; 2005 Sep; 9(9):1057-8. PubMed ID: 16158902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.